Research
Energy balance
Both treatments did not negatively impact fat-free mass after 3 months.
Both treatments can be used without concern for loss of lean body mass.
StrongSupportsmedium confidence
without a negative impact on fat-free mass.
Why this rating
The study design supports the assessment of body composition changes.
Source
The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario
Joana Nicolau et al. · Nutrición Hospitalaria · 2024
DOI 10.20960/nh.05244
cohort · n=179Cited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Subcutaneous semaglutide 0.5 mg and subcutaneous liraglutide 3 mg are effective treatments for reducing weight among people with obesity in a real-world scenario after 3 months.Strong
- There were no significant differences in the amount of weight lost between semaglutide 0.5 mg and liraglutide 3 mg after 3 months.Strong
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →